NCT03069469 2025-12-18Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell TumorDeciphera Pharmaceuticals, LLCPhase 1/2 Active not recruiting120 enrolled